Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
EPA CPDat observed this chemical in 110 composition records across product categories including Construction and building materials, Personal care.
Concern score
The concern value is driven by the published classifications and regulatory status below — not by a single signal.
Concern score 45/100 (moderate) · high confidence.
Prevalence of FRUCTOSE in our catalog (epa_cpdat).
Products
110
Brands
6
Typical roles
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Fragrance avoidance
Not a strong fit for fragrance avoidance because it carries Fragrance.
The ingredient itself is a fragrance-linked signal, so it is better treated as an avoid case when fragrance exposure is the main concern.
The published evidence profile currently shaping this ingredient record.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 110 composition records across product categories including Construction and building materials, Personal care. EPA CPDat classifies this chemical for functional uses including Humectant, Flavouring and nutrient, Fragrance.
US
FDA
Route: INTRAVENOUS; Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION; Maximum daily exposure: 205 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SOLUTION; Potency: 2625 mg/5ml
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 6000 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 13872 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Potency: 20 mg/1ml
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: SYRUP; Potency: 1732.5 mg/5ml
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 72 mg
US
FDA
Route: RECTAL; Dosage form: SOLUTION; Potency: 0.67 %w/v
US
FDA
FDA NDC lists this ingredient in 19 active drug products and 19 total products.
US
FDA
openFDA substance registry classifies this ingredient as concept.
US
FDA
openFDA substance registry classifies this ingredient as chemical.